Adenosine-mono-phosphate-activated protein kinase-independent effects of metformin in T cells.
The anti-diabetic drug metformin regulates T-cell responses to immune activation and is proposed to function by regulating the energy-stress-sensing adenosine-monophosphate-activated protein kinase (AMPK). However, the molecular details of how metformin controls T cell immune responses have not been...
Saved in:
| Main Authors: | Marouan Zarrouk, David K Finlay, Marc Foretz, Benoit Viollet, Doreen A Cantrell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0106710 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
LKB1 mediates the development of conventional and innate T cells via AMP-dependent kinase autonomous pathways.
by: Marouan Zarrouk, et al.
Published: (2013-01-01) -
Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation
by: Diana Vara-Ciruelos, et al.
Published: (2025-07-01) -
Metformin augments doxorubicin cytotoxicity in mammary carcinoma through activation of adenosine monophosphate protein kinase pathway
by: Nahla E El-Ashmawy, et al.
Published: (2017-04-01) -
Adenosine Monophosphate-Activated Protein Kinase, Oxidative Stress, and Diabetic Endothelial Dysfunction
by: Ming-Hui Zou, et al.
Published: (2021-03-01) -
Down-regulation of adenosine monophosphate–activated protein kinase activity: A driver of cancer
by: Xiaoling He, et al.
Published: (2017-04-01)